IE38886B1 - Heterocyclic compounds - Google Patents
Heterocyclic compoundsInfo
- Publication number
- IE38886B1 IE38886B1 IE00249/74A IE24974A IE38886B1 IE 38886 B1 IE38886 B1 IE 38886B1 IE 00249/74 A IE00249/74 A IE 00249/74A IE 24974 A IE24974 A IE 24974A IE 38886 B1 IE38886 B1 IE 38886B1
- Authority
- IE
- Ireland
- Prior art keywords
- alkyl group
- hydrogen atom
- group
- compounds
- hydroxy
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000004423 acyloxy group Chemical group 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 abstract 1
- XOQQVKDBGLYPGH-UHFFFAOYSA-N 2-oxo-1h-quinoline-3-carboxylic acid Chemical compound C1=CC=C2NC(=O)C(C(=O)O)=CC2=C1 XOQQVKDBGLYPGH-UHFFFAOYSA-N 0.000 abstract 1
- ULRPISSMEBPJLN-UHFFFAOYSA-N 2h-tetrazol-5-amine Chemical compound NC1=NN=NN1 ULRPISSMEBPJLN-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 150000008064 anhydrides Chemical class 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 125000000524 functional group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229960003540 oxyquinoline Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 150000003536 tetrazoles Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
1433774 Tetrazole-derived amides ALLEN & HANBURYS 6 Feb 1974 [26 Feb 1973] 9249/73 Heading C2C The invention comprises compounds of formula their 4-oxyquinoline tautomers (when R 4 =H) and pharmaceutically acceptable salts and esters thereof, in which : R 1 and R 2 which may be the same or different represent a hydrogen atom, a halogen atom, or an alkyl, trifluoromethyl or nitro group, or a group OR 3 in which R 3 represents a hydrogen atom, or an alkenyl or alkyl group, which alkyl group may be substituted by alkoxy, aryl, amino, alkylamino, dialkylamino, hydroxy or acyloxy groups; or a group NR 6 R 7 in which R 6 and R 7 which may be the same or different represent a hydrogen atom or an alkyl group, which alkyl group may be substituted with a hydroxy or acyloxy group, or in which R 6 and R 7 together with the nitrogen atom form a 5- or 6-membered ring which may contain additional hetero atoms; R 4 represents a hydrogen atom, an alkenyl or alkyl group, which alkyl group may be substituted with hydroxy, acyloxy, alkoxy, aryl, amino, alkylamino, dialkylamino or alkylaralkylamino groups; and R 5 represents a hydrogen atom or an alkyl group. In examples, these compounds are prepared by reacting the corresponding quinolonecarboxylic acid (A) (or a functional derivative thereof such as the acid chloride or the mixed anhydride with EtOCO 2 H) with 5-aminotetrazole and by the interconversion of functional groups in compounds thus prepared; the acids (A) are made by hydrolysing the corresponding esters. Therapeutic compositions for treating conditions primarily caused by antigen/reaginic antibody combination comprise compounds of the above formula, and may be administered orally or by inhalation.
[GB1433774A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB924973A GB1433774A (en) | 1973-02-26 | 1973-02-26 | Heterocyclic compounds apparatus for conveying articles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE38886L IE38886L (en) | 1974-08-26 |
| IE38886B1 true IE38886B1 (en) | 1978-06-21 |
Family
ID=9868317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE00249/74A IE38886B1 (en) | 1973-02-26 | 1974-02-08 | Heterocyclic compounds |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS5029574A (en) |
| AT (1) | AT329562B (en) |
| AU (1) | AU474797B2 (en) |
| BE (1) | BE811246A (en) |
| CA (1) | CA1025856A (en) |
| CH (1) | CH602707A5 (en) |
| DE (1) | DE2407744A1 (en) |
| FR (1) | FR2218896B1 (en) |
| GB (1) | GB1433774A (en) |
| IE (1) | IE38886B1 (en) |
| LU (1) | LU69479A1 (en) |
| NL (1) | NL7402613A (en) |
| SE (1) | SE7401984L (en) |
| ZA (1) | ZA74883B (en) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2324304A2 (en) * | 1975-09-22 | 1977-04-15 | Roussel Uclaf | Analgesic (4)-hydroxy-quinoline-(3)-amides - prepd. from a quinoline-(3)-carboxyl chloride and an amine |
| US4186201A (en) | 1977-02-07 | 1980-01-29 | Riker Laboratories, Inc. | Methods of using 8(tetrazol-5-ylcarbamoyl)isoquinoline compounds |
| US4264604A (en) | 1977-07-01 | 1981-04-28 | Ciba-Geigy Corporation | Quinolonecarboxylic acid derivatives as bactericides |
| US4390541A (en) | 1980-12-19 | 1983-06-28 | Lilly Industries Limited | Quinolone derivatives and their use in a method of controlling an immediate hypersensitivity disease |
| FR2509728A1 (en) * | 1981-07-17 | 1983-01-21 | Roussel Uclaf | NOVEL QUINOLINE DERIVATIVES, THEIR SALTS, PREPARATION METHOD, MEDICAMENT APPLICATION AND COMPOSITIONS COMPRISING THE SAME |
| US4377579A (en) | 1981-12-03 | 1983-03-22 | Minnesota Mining And Manufacturing Company | N-(Tetrazol-5-yl)phenazine-1-carboxamides |
| FR2537140B1 (en) * | 1982-12-07 | 1986-07-18 | Roussel Uclaf | NOVEL 4-HYDROXY-3-QUINOLEINE CARBOXAMIDE DERIVATIVES, SALTS THEREOF, PROCESS FOR THEIR PREPARATION, APPLICATION AS MEDICAMENTS, AND COMPOSITIONS CONTAINING THEM |
| US4965266A (en) * | 1987-01-20 | 1990-10-23 | Dainippon Pharmaceutical Co., Ltd. | Heteroarylcarboxamide derivatives, process for preparing the same and pharmaceutical composition containing the same |
| US4959363A (en) * | 1989-06-23 | 1990-09-25 | Sterling Drug Inc. | Quinolonecarboxamide compounds, their preparation and use as antivirals. |
| US6034100A (en) * | 1993-03-10 | 2000-03-07 | Otsuka Pharmaceutical Co., Ltd. | Method for inhibiting cytokine secretion |
| SK2162000A3 (en) * | 1997-08-25 | 2001-03-12 | Neurogen Corp | Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands |
| US6143760A (en) * | 1997-08-25 | 2000-11-07 | Neurogen Corporation | Substituted 4-oxo-napthyridine-3-carboxamides: GABA brain receptor ligands |
| JP2002504544A (en) | 1998-02-26 | 2002-02-12 | ニューロゲン コーポレイション | Substituted cycloalkyl-4-oxonicotinic acid carboxamides; GABA brain receptor ligands |
| JP4532263B2 (en) * | 2002-05-14 | 2010-08-25 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Substituted quinolone carboxylic acids, derivatives thereof, sites of action, and uses thereof |
| EP1650192A4 (en) | 2003-07-24 | 2007-03-21 | Astellas Pharma Inc | Quinolone derivative or salt thereof |
| EP3705477A1 (en) * | 2004-06-24 | 2020-09-09 | Vertex Pharmaceuticals Incorporated | Modulators of atp-binding cassette transporters |
| US8354427B2 (en) | 2004-06-24 | 2013-01-15 | Vertex Pharmaceutical Incorporated | Modulators of ATP-binding cassette transporters |
| CN104788328B (en) * | 2004-06-24 | 2017-09-12 | 沃泰克斯药物股份有限公司 | The adjusting control agent of ATP combination cassette transporters |
| RU2556984C2 (en) * | 2004-06-24 | 2015-07-20 | Вертекс Фармасьютикалз Инкорпорейтед | Modulators of atp-binding cassette transporters |
| WO2007079139A2 (en) | 2005-12-28 | 2007-07-12 | Vertex Pharmaceuticals, Inc. | Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
| US12458635B2 (en) | 2008-08-13 | 2025-11-04 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| SG10201504084QA (en) | 2009-03-20 | 2015-06-29 | Vertex Pharma | Process for making modulators of cystic fibrosis transmembrane conductance regulator |
| US8802700B2 (en) | 2010-12-10 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
| CN109966264A (en) | 2012-02-27 | 2019-07-05 | 沃泰克斯药物股份有限公司 | Pharmaceutical compositions and their administration |
| WO2013129622A1 (en) | 2012-03-02 | 2013-09-06 | 武田薬品工業株式会社 | Heterocyclic compound and use therefor |
| JP6211530B2 (en) | 2012-11-19 | 2017-10-11 | 武田薬品工業株式会社 | Nitrogen-containing heterocyclic compounds |
| US9701639B2 (en) | 2014-10-07 | 2017-07-11 | Vertex Pharmaceuticals Incorporated | Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator |
| CN105330602B (en) * | 2015-12-07 | 2018-02-09 | 江南大学 | A kind of deccox analog and its application |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1383088A (en) * | 1972-07-03 | 1975-02-05 | Allen & Hanburys Ltd | Pharmacologically active quinaldamide derivatives |
-
1973
- 1973-02-26 GB GB924973A patent/GB1433774A/en not_active Expired
-
1974
- 1974-02-08 IE IE00249/74A patent/IE38886B1/en unknown
- 1974-02-11 ZA ZA740883A patent/ZA74883B/en unknown
- 1974-02-14 SE SE7401984A patent/SE7401984L/xx unknown
- 1974-02-14 AU AU65592/74A patent/AU474797B2/en not_active Expired
- 1974-02-18 CH CH224374A patent/CH602707A5/xx not_active IP Right Cessation
- 1974-02-18 DE DE19742407744 patent/DE2407744A1/en active Pending
- 1974-02-19 BE BE141102A patent/BE811246A/en unknown
- 1974-02-22 LU LU69479A patent/LU69479A1/xx unknown
- 1974-02-25 FR FR7406327A patent/FR2218896B1/fr not_active Expired
- 1974-02-25 AT AT149974A patent/AT329562B/en not_active IP Right Cessation
- 1974-02-25 JP JP49022232A patent/JPS5029574A/ja active Pending
- 1974-02-26 CA CA193,476A patent/CA1025856A/en not_active Expired
- 1974-02-26 NL NL7402613A patent/NL7402613A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA74883B (en) | 1974-12-24 |
| FR2218896B1 (en) | 1977-09-09 |
| AU474797B2 (en) | 1976-08-05 |
| ATA149974A (en) | 1975-08-15 |
| CH602707A5 (en) | 1978-07-31 |
| BE811246A (en) | 1974-08-19 |
| AU6559274A (en) | 1975-08-14 |
| LU69479A1 (en) | 1975-05-21 |
| IE38886L (en) | 1974-08-26 |
| GB1433774A (en) | 1976-04-28 |
| DE2407744A1 (en) | 1974-08-29 |
| FR2218896A1 (en) | 1974-09-20 |
| NL7402613A (en) | 1974-08-28 |
| CA1025856A (en) | 1978-02-07 |
| AT329562B (en) | 1976-05-25 |
| SE7401984L (en) | 1974-08-27 |
| JPS5029574A (en) | 1975-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE38886B1 (en) | Heterocyclic compounds | |
| IE37519B1 (en) | Novel amino derivatives of quinoxaline and quinazoline | |
| NO163956C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE (4-PIPERIDINYLMETHYL-HETERO) PURINES. | |
| FI900085A0 (en) | Process for Preparing Therapeutically Useful N- (Pyrimidine and Condensed Pyrimidin-4-One) Ethyl-Piperidine and Piperinated Zine Derivatives | |
| NO903438D0 (en) | PROCEDURE FOR THE PREPARATION OF TIAZOLD DERIVATIVES. | |
| DE69428142D1 (en) | Quinoline or quinazoline derivatives, their preparation and use | |
| IE37795L (en) | Quinaldamide derivatives | |
| IE812683L (en) | Thieno-pyridine derivatives | |
| ATE3284T1 (en) | DERIVATIVES OF 9-CIS-6,6'-DIAPO-PSI,PSICAROTINDIS[URE, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| IE33850L (en) | Pyridoindole derivatives. | |
| GB1530413A (en) | 5,8-dihydro-5-oxopyrido(2,3-d)pyrimidines | |
| GB1008849A (en) | Basically substituted triazolidines, processes for their manufacture and pharmaceutical preparations containing them | |
| GB1398687A (en) | Substituted oxazolidinones and pharmaceutical uses thereof | |
| GB1463256A (en) | Dioxamic acid derivatives | |
| JPS55129268A (en) | Carbostyril derivative | |
| GB1413407A (en) | Dihydropyrido-pyrimidine derivatives their preparation and therapeutical use | |
| IE56310B1 (en) | Acridanone derivatives | |
| GB1434645A (en) | Tetrazole coumarin derivatives | |
| SE8502310L (en) | NEW CINOLINE DERIVATIVES, SET TO MAKE THESE AND THERAPEUTIC COMPOSITIONS, CONTAINING THEM | |
| GB1488412A (en) | Imidazo(1,2-a)quinolines | |
| GB1422831A (en) | Acylaminobenzimidazole derivatives | |
| JPS5273875A (en) | Synthesis of carbostyril-carboxylic acid derivatives | |
| GB1453427A (en) | 4-oxo-1,2,3,4-tetrahydropyrido-2,3-d-pyrimidines | |
| KR880012613A (en) | Quinolinecarboxylic acid derivatives and antibiotics containing the same |